Alumis Inc.
ALMSBiotechnology
$6.89−3.37%As of Oct 29vs prior close
- Market cap
- $891.8M
- P/E (TTM)
- –
- From 52W high
- −77.26%
- EPS (LTM)
- -$3.66
- Revenue (LTM)
- $7.4M
- Net margin
- -5933.45%
- Dividend yield
- 0.00%
Nomior Score
27
Steady ProfileBottom 12% of the scored universe
Growth52
Quality22
Value22
Momentum56
Resilience34
Growth
$7.4Mrevenue, LTM
YE25 $24.1MLTM $7.4M
Connections
Revenue to profitQ2 YE26
The operating loss was 8956% of revenue, wider by 3685 pts on a year.
Who owns it
2funds